You should give evidence. If you really have done any in-depth research on CFDA/SAMR, you will know you’re wrong.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025